Lipid-lowering drugs in treatment of hyperlipidaemia associated with nephrotic syndrome

Lancet. 1989 May 6;1(8645):1029. doi: 10.1016/s0140-6736(89)92681-0.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Drug Evaluation, Preclinical
  • Hyperlipidemias / drug therapy*
  • Lovastatin / therapeutic use*
  • Male
  • Nephrotic Syndrome / complications*
  • Random Allocation
  • Rats

Substances

  • Lovastatin